Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by deepoil0808on Nov 21, 2021 2:19am
589 Views
Post# 34150213

Accounts Receivables of $ 25 million are UNCOLLECTED

Accounts Receivables of $ 25 million are UNCOLLECTEDA major red flag I see is the uncollected accounts receivable of $ 25 million.

During the quarter there were many complaints against the company.   People getting conflicting test results, some people not getting results at all, some people having to wait a very long time before getting results, some people never emailed results, etc...

The situation got out of hand that they had to leave East Hampton and, that authorities in California are investigating 2 cubes because of this and, have told people to use other testing sites.

This is not good.

So what tells me that the $ 25 million in receivables is indeed collectible?    How many of these fees are the subject of complaints?   With any of the fees have to be reversed?   And why is company rushing for a 1 for 15 reverse stock split if they are supposed to have the funds in the company via the receivables?

And why are payables out of hand?   Does this mean no one is getting paid?  How about the employees?

We had sales in July 2021, you mean to tell me that as of end of October 2021 it is still not collected?   

The testing amounts are not material, it is $ 150, it should not take 3 months to process it.   It is like a dental bill, usually 3 weeks and insurance pays.   Why 3 months?

Many unanswered questions.

PS:    Company made many investments and, a good chunk were written off as worthless.
          Will it also be the same for receivables?   How do I know that they  remain collectible?

My personal opinion of course, 
<< Previous
Bullboard Posts
Next >>